The last 20 actions on file set price targets from $32.00 to $55.00, averaging $39.32.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 29 Sep 2026 | TD Cowen | BUY | $34.00 |
| 29 Sep 2026 | Truist Financial | BUY | $32.00 |
| 29 Sep 2026 | Evercore | BUY | $44.00 |
| 29 Sep 2026 | Citi | BUY | $39.00 |
| 28 Sep 2026 | LifeSci Capital | BUY | $34.00 |
| 28 Sep 2026 | Citi | BUY | $39.00 |
| 17 Sep 2026 | Wolfe Research | BUY | – |
| 10 Sep 2026 | Citi | BUY | $38.00 |
| 3 Sep 2026 | J.P. Morgan | BUY | $33.00 |
| 26 Aug 2026 | Bloom Burton | BUY | $37.00 |
| 26 Aug 2026 | Citi | BUY | $38.00 |
| 26 Aug 2026 | H.C. Wainwright | BUY | $55.00 |
| 25 Aug 2026 | Wells Fargo | BUY | $40.00 |
| 25 Aug 2026 | LifeSci Capital | BUY | $34.00 |
| 11 Aug 2026 | Truist Financial | BUY | $32.00 |
| 11 Aug 2026 | Stifel | BUY | $46.00 |
| 10 Aug 2026 | Citi | BUY | $37.00 |
| 10 Aug 2026 | B. Riley Securities | BUY | $44.00 |
| 10 Aug 2026 | H.C. Wainwright | BUY | $51.00 |
| 7 Aug 2026 | Wells Fargo | BUY | $40.00 |
No comments yet — be the first to weigh in on ZYME.